Medicine
Cefepime 2 g/50 mL injection
Cefepime 2 g/50 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store the unactivated unit at 20–25°C (68–77°F). Excursions…
Key facts
- Active ingredient (INN)
- Cefepime
- Brand
- Sold under the generic name
- Strength
- 2 g/50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 containers of 50 mL
- Manufacturer
- B. Braun Medical
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store the unactivated unit at 20–25°C (68–77°F). Excursions permitted to 15–30°C (59–86°F). As with other cephalosporins, reconstituted Cefepime for Injection USP and Dextrose Injection USP tends to darken depending on storage conditions, within the stated recommendations.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DE01 Cefepime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 May 2010
- Identifiers
- RxCUI 1665088, 1665093DailyMed set ID 57517a0e-ec1b-4605-a7cc-7e3801158ec9NDC 0264-3195Application NDA050821
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 container in 1 case / 50 mL in 1 container | 0264-3195-11 | B. Braun Medical | 6 May 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 January 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefepime
Clinical summary
Cefepime is a cephalosporin antibacterial indicated in the treatment of infections caused by susceptible isolates of the designated microorganisms, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Cefepime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefepimeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefepime prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Cefepime 2 g/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.